Formulation studies of innovative topical systems with N-acetyl-D-glucosamine and quercetin by Almeida Santos, Carolina et al.
• The best droplet size distribution was obtained with ULTRA-
TURRAX®: the average droplet diameter corresponding to percentile
90 was 6.954 μm, 9.396 μm and 26.793 μm for the ULTRA-
TURRAX®, TURBOTEST evo and EUROSTAR 60 digital,
respectively, as shown in Figure 1.
• The formulation obtained with the ULTRA-TURRAX® showed a
shear-thinning behaviour and the addition of quercetin and GlcNAc
neither altered this profile (Figure 2), nor the droplet size distribution
(Figure 3) nor pH and conductivity (Table 1).
• The oil/water ratio was also studied and the results showed that
smaller droplets were obtained with the highest volume fraction of
water, as well as the highest conductivity and the lowest viscosity.
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The aim of this work was to develop and characterise two topical
emulsions, one containing quercetin (lipophilic compound) and another
with GlcNAc (hydrophilic compound).
Aim
Emulsions were prepared with three different equipment: EUROSTAR
60 digital (helix stirrer), T25 digital ULTRA-TURRAX® and Turbotest
evo (defocculator) and their droplet size was characterised. The final
formulations were prepared using T25 digital ULTRA-TURRAX® and
characterised according to the following methods:
 Droplet size: determined with a Malvern Mastersizer 2000 (Malvern
Instruments, UK), coupled with a Hydro S accessory;
 Rheological profile: measured with an RVTDV II Brookfield®
viscometer (Brookfield Engineering Laboratories, USA);
 pH and Conductivity: determined with the S20 SevenEasyTM pH
(Mettler Toledo, USA);
 Microscopy: the emulsions were observed under a light microscope
(Olympus BX51, Japan) with 10x objectives with normal light.
Materials and Methods
 Homogenisation by ULTRA-TURRAX® was the most effective to
obtain smaller droplets.
 The emulsions obtained so far suggest promising results with regard
to their efficacy as innovative anti-ageing quercetin and GlcNAc
topical systems.
Conclusions
 The skin is the largest organ of the human body and two of its main
functions are protection and thermoregulation [1]. With ageing, skin
loses its structural and morphological characteristics, and therefore
its functions. Both quercetin and N-Acetyl-D-Glucosamine (GlcNAc)
have been extensively studied regarding their potential to prevent
skin ageing.
 Quercetin is a powerful anti-oxidant and anti-inflammatory already
proven to be effective against extrinsic skin aging factors
[2]. GlcNAc, is a monosaccharide derived from glucose [3] and has
shown promising skincare properties, such as increasing skin
hydration, wrinkle reduction and anti-ageing [4].
 Oil-in-water (O/W) and water-in-oil (W/O) emulsions have been
widely used due to their efficacy in delivering compounds topically
and their stability is very important: an emulsion with smaller oil
droplets is empirically known to be more stable [5,6].
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Figure 1. Droplet size distribution profile of the
topical emulsion without drugs and using different
equipments.
0
2
4
6
8
10
12
0.01 0.1 1 10 100 1000 10000
V
o
lu
m
e
 (
%
)
Droplet size (µm)
Droplet size
Quercetin Reference NAG
0
150
300
450
600
750
0 50 100 150
σ
(m
P
a
)
γ (1/s)
Rheological profiles
Up-curve Reference Down-curve Reference
Up-curve Quercetin Down-curve Quercetin
Reference Quercetin GlcNAc
pH (20ºC) 5.78 ± 0.05 5.97 ± 0.04 5.56 ± 0.04
Conductivity
(mV)
74.30 ± 3.00 63.70 ± 2.00 87.00 ± 1.00
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Figure 2. Rheological profile of final
formulations.
Figure 3. Droplet size distribution profile of
final formulations.
Quercetin (x400) GLcNAc (x200)
Figure 4. Microscopical structure – final
formulations containing quercitin and
GLcNAc.
Table 1. pH and conductivity values of final
formulations (mean ± SD, n = 3).
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The emulsion prepared
with ULTRA-TURRAX®
was the one with the
best droplet size
distribution and the most
effective in obtaining
smaller droplets.
